Concepedia

Matthew Campbell

MC

Statistics

Publications

28

Citations

2.7K

H-Index

24

Active since

1988

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

GlaxoSmithKline (United States)

University of North Carolina at Chapel Hill

University of Strathclyde

Age UK

Matthew Campbell is an author at GlaxoSmithKline (United Kingdom) specializing in chemistry, medicinal chemistry, and drug discovery.

ORCID

Publications per year

1988–2023

28

Publications

28

Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation

Huw D. Lewis, John Liddle, Jim Coote et al. · Nature Chemical Biology · 2015 · 760 citations · Full text

, , +2

Discovery of a Potent and Orally Active Hedgehog Pathway Antagonist (IPI-926)

Martin Tremblay, André Lescarbeau, Michael J. Grogan et al. · Journal of Medicinal Chemistry · 2009 · 251 citations · Full text

, , +17

Complexity-Building Annulations of Strained Cycloalkanes and C═O π Bonds

Matthew Campbell, Jeffrey S. Johnson, Andrew T. Parsons et al. · The Journal of Organic Chemistry · 2010 · 186 citations

, , +13

Mechanistic Studies of the Copper-Catalyzed Electrophilic Amination of Diorganozinc Reagents and Development of a Zinc-Free Protocol

Matthew Campbell, Jeffrey S. Johnson · Organic Letters · 2007 · 176 citations

, , +10

Diastereoselective Synthesis of Tetrahydrofurans via Palladium(0)-Catalyzed [3 + 2] Cycloaddition of Vinylcyclopropanes and Aldehydes

Andrew T. Parsons, Matthew Campbell, Jeffrey S. Johnson · Organic Letters · 2008 · 166 citations

, , +13

1–5 of 28